Exosomes – News and Features

UC Riverside scientists have discovered a stealth molecular weapon that plants use to attack the cells of invading gray mold.

A newly developed blood test could identify the pathology that triggers Parkinson's disease before symptoms occur, allowing clinicians to screen those at high risk of the disease.

This article reviews the studies and methods powering our growing understanding of the mechanisms behind neurodegenerative disease.

Researchers have loaded extracellular vesicles with therapeutic mRNA, and shown how they can be used to enhance immunotherapy responses in glioblastoma.

Researchers found exposing cells to a small molecule drug improved their fitness during hematopoietic stem cell transplants, which could broaden access and improve outcomes for ex vivo gene therapy.

Polycystic ovarian syndrome (PCOS) affects millions of women and is notoriously difficult to treat. A new treatment has been unveiled that may improve multiple PCOS symptoms.

Defective exosomes, which shuttle signals between cells, can drive inflammation and impair wound healing in diabetic patients, according to a new study.

Researchers wanted to understand how cells react to these extracellular vesicles (EVs) produced by different cell types and at varying concentrations.

It has been suspected for some time that viral infections contribute to the genesis and development of neurodegenerative diseases. Laboratory studies now suggest a mechanism that does not require infection by external pathogens.

Hans van der Voorn tells us about some of the recent progress in the extracellular vesicle-based diagnostics and therapeutics landscape, particularly the need for industrial-scale EV isolation workflows.